Barclays PLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 15, 2024	BUY	$1024.09 - $1201.76 $3.69 Million - $4.33 Million	3,600 New	3,600 $3.79 Million
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $7.95 Million - $10.7 Million	14,500 Added 48.33%	44,500 $26.3 Million
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $9.29 Million - $11.4 Million	20,800 Added 226.09%	30,000 $14.2 Million
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $1.34 Million - $1.7 Million	2,800 Added 43.75%	9,200 $4.44 Million
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $1.2 Million - $1.45 Million	-2,200 Reduced 25.58%	6,400 $3.58 Million
Q2 2020 Aug 12, 2020	SELL	$493.32 - $643.92 $10.3 Million - $13.4 Million	-20,800 Reduced 70.75%	8,600 $5.36 Million
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $9.21 Million - $13.5 Million	-27,400 Reduced 48.24%	29,400 $14.4 Million
Q4 2019 Feb 10, 2020	BUY	$274.13 - $376.51 $4.91 Million - $6.74 Million	17,900 Added 46.02%	56,800 $21.3 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $5 Million - $5.83 Million	-18,300 Reduced 31.99%	38,900 $10.8 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $9.95 Million - $13.8 Million	-33,200 Reduced 36.73%	57,200 $17.9 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $13 Million - $15.4 Million	35,000 Added 63.18%	90,400 $37.1 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $3.93 Million - $4.72 Million	-11,700 Reduced 17.44%	55,400 $20.7 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $19.1 Million - $22.3 Million	-54,500 Reduced 44.82%	67,100 $27.1 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $1.45 Million - $1.76 Million	5,100 Added 4.38%	121,600 $42 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $2.46 Million - $3.07 Million	-7,800 Reduced 6.28%	116,500 $40.1 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $10.9 Million - $14.3 Million	30,500 Added 32.52%	124,300 $46.7 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $40.5 Million - $47.3 Million	93,800	93,800 $41.9 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account